Deep learning may be a viable alternative to gadolinium-based contrast agents for identifying enhancing lesions in multiple sclerosis on MRI scans. Background Enhancing lesions on MRI scans obtained after contrast material administration are commonly thought to represent disease activity in multiple sclerosis (MS); it is desirable to develop m...